[1] ACERO-GARCÉS D O,GARCÍA-PERDOMO H A.First line treatments for newly diagnosed primary immune thrombocytopenia in children: a systematic review and network meta-analysis[J].Curr Pediatr Rev,2020,16(1): 61-70. [2] RODEGHIERO F,STASI R,GERNSHEIMER T,et al.Standardization of terminology,definitions and outcome criteria in immune thrombocytopenic purpura of adults and children:report from an international working group[J].Blood,2009,113(11):2386-2393. [3] SEMPLE J W,REBETZ J,MAOUIA A,et al.An update on the pathophysiology of immune thrombocytopenia[J]. Curr Opin Hemato,2020,27(6):423-429. [4] XIAO Z X,MILLER J S,ZHENG S G.An updated advance of autoantibodies in autoimmune diseases[J]. Autoimmun Rev,2020:102743. [5] WANG Y M,YU Y F,LIU Y,et al.The association between antinuclear antibody and response to rituximab treatment in adult patients with primary immune thrombocytopenia[J].Hematology,2020,25(1):139-144. [6] MOULIS G,COMONT T,GERMAIN J,et al.Significance of antinuclear antibodies in primary immune thrombocytopenia: results of the CARMEN registry[J].Blood Adv,2020,4(9):1974-1977. [7] 中华医学会儿科学分会血液学组.儿童原发性免疫性血小板减少症诊疗建议[J].中华儿科杂志,2013, 51(3):382-384. [8] 胡亚美,江载芳.诸福棠实用儿科学[M]. 北京:人民卫生出版社,2002: 1800-1801. [9] OKUBO Y,MICHIHATA N,MORISAKI N,et al.Recent trends in practice patterns and comparisons between immunoglobulin and corticosteroid in pediatric immune thrombocytopenia[J].Int J Hematol,2018,107(1):75-82. [10] BOULWARE R,REFAAI M A.Why do patients with immune thrombocytopenia (ITP) experience lower bleeding events despite thrombocytopenia?[J].Thromb Res,2020,187:154-158. [11] HEITINK-POLLÉ K M J,UITERWAAL C S P M,PORCELIJN L,et al.Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial[J].Blood,2018,132(9):883-891. [12] BENNETT C M,NEUNERT C,GRACE R F,et al.Predict ors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants[J].Pediatr Blood Cancer,2018,65(1). [13] 郑金菊,牟晓峰.抗核抗体核型检测与特异性抗核抗体谱检测的对比分析[J].国际检验医学杂志,2014,35(20): 2813-2815. [14] FANOURIAKIS A,BERTSIAS G,BOUMPAS D T.Population-based studies in systemic lupus erythematosus: immune thrombocytopenic Purpura or"blood-dominant"lupus?[J].Ann Rheum Dis,2020,79(6): 683-684. [15] 郑浩,顾晓琼,高飞,等.特发性血小板减少症患儿抗核抗体及可提取性核抗原多肽抗体谱特点分析[J].实用心脑肺血管病杂志,2015,23(5): 137-139. |